Company
Sanofi SA (ADR)
NYSE:SNY
Sanofi is a global healthcare company. Focused on patients’ needs, Sanofi offers a range of essential healthcare assets, including a broad-based product portfolio and a presence worldwide.
15 stories
Sanofi’s blockbuster Dupixent drug clears major trial
Currently used for treating asthma, Dupixent also shows promise in treating ‘smoker’s lung’
Berkshire Hathaway’s 13-F filing reveals Warren Buffett added $4B stake in JPMorgan
Buffett’s company bought a new stake in JPMorgan and upped its investment in Apple
Sanofi shares dip as 1Q earnings hit by loss of patent protection for blockbuster diabetes drug
Sanofi’s diabetes division reported a 16% fall in sales in the first quarter after its blockbuster diabetes drug, Lantus, lost patent exclusivity in the US and came under pressure from cheaper copycats
Advent International in talks to buy French drugs giant Sanofi's European generics business
The business, Zentiva operates in 50 markets and has a strong presence in Eastern Europe, particularly in the Czech Republic, Slovakia and Romania
Investments and investor services
Benchmarks close at record highs
The three main indexes all finished at record highs
US stocks clinch record highs, Dow skids (just) shy of 20,000 after jobs report
US stocks clinched fresh record highs on Friday, with the Dow coming within a hair’s breadth of 20,000 – which can only have been helped by Goldman Sach’s shares driving 1.5% higher
Sanofi and Google form joint venture to tackle diabetes
The two companies will jointly invest around US$500mln in a joint venture, Onduo
Medivation faces buyers’ scrum - report
A scrum to acquire US cancer drug company Medivation was emerging on Wednesday after reports that Merck, Pfizer and Gilead Sciences were among at least five pharmaceutical companies expressing an interest
Medivation rejects latest Sanofi bid
Medivation officially rejects the latest acquisition bid of US$58 per share from Sanofi.
US stocks recover, but Viacom helps Nasdaq underperform
The Nasdaq lost ground by the Tuesday close, weighed down by big fallers such as media group Viacom, while the Dow and S&P were barely changed on the day after a late rally by sectors including healthcare countered another drop in oil price
Sanofi shares drop after counting cost of Allerject recall
Shares of French pharmaceuticals giant Sanofi fell on Tuesday, underperforming its peers, after the company reported the impact recalling anti-allergy drug Allerject had in its fourth quarter